Filing Details
- Accession Number:
- 0000784199-23-000052
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2023-03-01 18:41:45
- Reporting Period:
- 2023-02-23
- Accepted Time:
- 2023-03-01 18:41:45
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
784199 | Artivion Inc. | AORT | Surgical & Medical Instruments & Apparatus (3841) | 592417093 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1850597 | L. Rochelle Maney | 1655 Roberts Blvd., Nw Kennesaw GA 30144 | Vp, Quality | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2023-02-23 | 2,356 | $0.00 | 25,895 | No | 4 | A | Direct | |
Common Stock | Disposition | 2023-02-27 | 878 | $12.94 | 25,017 | No | 4 | S | Direct | |
Common Stock | Acquisiton | 2023-02-23 | 4,240 | $0.00 | 29,257 | No | 4 | A | Direct | |
Common Stock | Disposition | 2023-02-27 | 790 | $12.94 | 28,467 | No | 4 | A | Direct | |
Common Stock | Disposition | 2023-02-28 | 406 | $13.24 | 28,061 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | A | Direct | |
No | 4 | S | Direct | |
No | 4 | A | Direct | |
No | 4 | A | Direct | |
No | 4 | S | Direct |
Footnotes
- Represents performance stock units granted on Feb 23, 2022. Hundred percent (100%) were issued on Feb 23, 2023.
- These shares were sold upon the vesting of performance stock units to pay tax withholding obligations. The sale was to satisfy tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction.
- Represents performance stock units granted on Feb 23, 2022. Fifty percent (50%) were issued on Feb 23, 2023. The remaining shares earned in connection with the Feb 2022 grant will be eligible to vest and be issued as follows: 25% on 02/23/2024, and 25% on 02/23/2025, assuming continued employment on the relevant vesting date.
- These shares were sold upon the vesting of restricted stock units to pay tax withholding obligations. The sale was to satisfy tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction.